210 related articles for article (PubMed ID: 36350434)
1. Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice.
Liang M; Zhang J; Yang Y; Xia Y; Liu L; Liu L; Wang Q; Gao X
World J Microbiol Biotechnol; 2022 Nov; 39(1):8. PubMed ID: 36350434
[TBL] [Abstract][Full Text] [Related]
2. The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice.
Garrido-Mesa N; Utrilla P; Comalada M; Zorrilla P; Garrido-Mesa J; Zarzuelo A; Rodríguez-Cabezas ME; Gálvez J
Biochem Pharmacol; 2011 Dec; 82(12):1891-900. PubMed ID: 21930116
[TBL] [Abstract][Full Text] [Related]
3. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
Ukena SN; Singh A; Dringenberg U; Engelhardt R; Seidler U; Hansen W; Bleich A; Bruder D; Franzke A; Rogler G; Suerbaum S; Buer J; Gunzer F; Westendorf AM
PLoS One; 2007 Dec; 2(12):e1308. PubMed ID: 18074031
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects resulting from oral administration of
Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.
Schultz M; Strauch UG; Linde HJ; Watzl S; Obermeier F; Göttl C; Dunger N; Grunwald N; Schölmerich J; Rath HC
Clin Diagn Lab Immunol; 2004 Mar; 11(2):372-8. PubMed ID: 15013990
[TBL] [Abstract][Full Text] [Related]
6. Probiotic
Teng G; Liu Z; Liu Y; Wu T; Dai Y; Wang H; Wang W
Front Microbiol; 2022; 13():819336. PubMed ID: 35602072
[TBL] [Abstract][Full Text] [Related]
7. [Elafin-expressing probiotic Escherichia coli Nissle 1917 protects against experimental colitis].
Liu ZL; Wang WH; Liu Y; Wu T; Teng GG
Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3819-3824. PubMed ID: 34895424
[No Abstract] [Full Text] [Related]
8. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut.
Praveschotinunt P; Duraj-Thatte AM; Gelfat I; Bahl F; Chou DB; Joshi NS
Nat Commun; 2019 Dec; 10(1):5580. PubMed ID: 31811125
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model.
Souza ÉL; Elian SD; Paula LM; Garcia CC; Vieira AT; Teixeira MM; Arantes RM; Nicoli JR; Martins FS
J Med Microbiol; 2016 Mar; 65(3):201-210. PubMed ID: 26758971
[TBL] [Abstract][Full Text] [Related]
10. Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis.
Yan X; Liu XY; Zhang D; Zhang YD; Li ZH; Liu X; Wu F; Chen GQ
Cell Mol Immunol; 2021 Oct; 18(10):2344-2357. PubMed ID: 34480146
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
[TBL] [Abstract][Full Text] [Related]
12. Homeostasis effects of fermented Maillard reaction products by Lactobacillus gasseri 4M13 in dextran sulfate sodium-induced colitis mice.
Jeong YJ; Kim DH; Lee KW
J Sci Food Agric; 2022 Jan; 102(1):434-444. PubMed ID: 34143895
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from
Fábrega MJ; Rodríguez-Nogales A; Garrido-Mesa J; Algieri F; Badía J; Giménez R; Gálvez J; Baldomà L
Front Microbiol; 2017; 8():1274. PubMed ID: 28744268
[No Abstract] [Full Text] [Related]
14. Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice.
Tang H; Zhou T; Jin W; Zong S; Mamtimin T; Salama ES; Jeon BH; Liu P; Han H; Li X
Life Sci; 2023 Jul; 324():121709. PubMed ID: 37100380
[TBL] [Abstract][Full Text] [Related]
15. Modified Prebiotic-Based "Shield" Armed Probiotics with Enhanced Resistance of Gastrointestinal Stresses and Prolonged Intestinal Retention for Synergistic Alleviation of Colitis.
Xie A; Ji H; Liu Z; Wan Y; Zhang X; Xiong H; Nie SP; Wan H
ACS Nano; 2023 Aug; 17(15):14775-14791. PubMed ID: 37477584
[TBL] [Abstract][Full Text] [Related]
16. The Administration of
Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; Fernández-Caballero JA; García F; Rodríguez-Cabezas ME; Gálvez J
Front Pharmacol; 2018; 9():468. PubMed ID: 29867475
[TBL] [Abstract][Full Text] [Related]
17. E.coli Nissle increases transcription of flagella assembly and formate hydrogenlyase genes in response to colitis.
Dacquay LC; Tsang D; Chan D; Parkinson J; Philpott DJ; McMillen DR
Gut Microbes; 2021; 13(1):1994832. PubMed ID: 34751631
[No Abstract] [Full Text] [Related]
18. Modulation of Gut Microbiota Combined with Upregulation of Intestinal Tight Junction Explains Anti-Inflammatory Effect of Corylin on Colitis-Associated Cancer in Mice.
Chang ZY; Liu HM; Leu YL; Hsu CH; Lee TY
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269806
[TBL] [Abstract][Full Text] [Related]
19. Anti-Inflammatory and Gut Microbiota Modulating Effects of Probiotic
Ladda B; Jantararussamee C; Pradidarcheep W; Kasorn A; Matsathit U; Taweechotipatr M
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986118
[TBL] [Abstract][Full Text] [Related]
20. Semi-Rational Screening of Probiotics from the Fecal Flora of Healthy Adults against DSS-Induced Colitis Mice by Enhancing Anti-Inflammatory Activity and Modulating the Gut Microbiota.
Wang W; Xing W; Wei S; Gao Q; Wei X; Shi L; Kong Y; Su Z
J Microbiol Biotechnol; 2019 Sep; 29(9):1478-1487. PubMed ID: 30270604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
